Utah Medical’s Valuation Premium Meets Revenue and Cost Pressures
Zacks cites Utah Medical’s cash position and acquisition alongside falling revenue, higher costs and a valuation above the industry average.
Makkler Newsroom · Oct 8, 09:45 PM · 1 min read
